Nadia Ali, MD

Clinical Interests

• Multiple myeloma
• Precision medicine application to hematologic malignancies

Research Interests

• Multiple myeloma
• Precision medicine application to hematologic malignancies

Educational Background

• Fellowship, Hematology/Oncology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 
• Residency, Internal Medicine, Montefiore Medical Center, Albert Einstein School of Medicine, New York City, NY 
• MD, Southern Illinois University, School of Medicine, Springfield, IL 

Certifications

• Internal Medicine

Memberships

• American Society of Hematology
• American Society of Clinical Oncology

Honors & Awards

• Chief Fellow, Hematology/Oncology Rutgers RWJ, June 2016 
• SIU SOM Mentored Professional Enrichment Experience participant and grant recipient, 2008 
• Dartmouth College Dean of Faculty Grant Recipient from the Richter Memorial Fund, Summer 2006, Spring and Winter 2007

Additional Publications

• Schrock AB, Hirshfield KM, Ali N, Ganesan S, Ali SM, Miller VA, Stephens PJ2, Ross JS, Chung JH. Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Breast Cancer Res Treat. 2017 Apr;162(3):597-602. 
• Nadia Ali and David Weismann. Charcot Leyden crystals and bone marrow necrosis in T-cell lymphoblastic leukemia/lymphoma. Blood. 2017 19;129(3):394 
• Yvonne Sun, Ruth L. Gustavson, Nadia Ali, Karrie A. Weber, Lacey L. Westphal and John D. Coates. Behavioral response of dissimilatory perchlorate-reducing bacteria to different electron acceptors. Appl Microbiol Biotechnol (2009) 84:955–963